India In-Vitro Diagnostics Industry Analysis till 2018
Accreditation and Automation to Drive Future Growth
October 2013
129
About the Report
About the Report
Products
Products
in-vitro diagnostics, immunochemistry, reagents and instruments, coagulation, biochemistry, hematology, microbiology, ELISA kits and rapid tests, micr
Companies
Roche Diagnostic, Abbott Laboratories, Transasia Biomedicals, Siemens Healthcare, Beckman Coulter, Becton and Dickinson and Sysmex
Table of Contents
Table of Contents
1. India In-Vitro Diagnostics Market Introduction
Market Overview
Growth Drivers
Constraints
Regulatory Framework and Accreditation
2. India In-Vitro Diagnostics Market Size by Revenues, FY'2007-FY'2013
3. India In-Vitro Diagnostics Market Segmentation
3.1. By Reagents and Instruments, FY'2010-FY'2013
3.2. By Urban and Rural Areas, FY'2013
3.3. By Type of Tests, FY'2007-FY'2013
4. India Immunochemistry Market
4.1. Market Scenario
Market Overview
Drivers
Constraints
Emerging Technology Trends
4.2. India Immunochemistry Market Size, FY'2007- FY'2013
4.3. India Immunochemistry Market Segmentation Reagents and Instruments, ELISA Kits and Rapid Tests, FY'2007-FY'2013
4.3.1. India Immunochemistry Instruments and Reagents Market Size, FY'2007-FY'2013
4.3.2. India Immunochemistry Instruments and Reagents Market Segmentation By Type of Tests, FY'2007-FY'2013
4.3.3. India Immunochemistry Reagents Market Segmentation by End Use, FY'2007-FY'2013
4.4. Market Share of Major Players in India Immunochemistry Market, FY'2013
5. India Biochemistry Market
5.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
5.2. India Biochemistry Market Size, FY'2007 - FY'2013
5.3. India Biochemistry Market Segmentation by Reagents and Instruments, FY'2007-FY'2013
5.4. Market Share of Major Players in India Biochemistry Market, FY'2013
6. India Hematology Market
6.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
6.2. India Hematology Market Size, FY'2007-FY'2013
6.3. India Hematology Market Segmentation By Reagents and Instruments, FY'2007-FY'2013
6.4. India Hematology Market Competitive Landscape
7. India Microbiology Market
7.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
7.2. India Microbiology Market Size, FY'2007-FY'2013
7.3. India Microbiology Market Segmentation by Reagents and Instruments, FY'2008-FY'2013
7.4. Market Share of Major Players in India Microbiology Market, FY'2013
8. India Blood Gas and Electrolyte Market
8.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
8.2. India Blood Gas and Electrolyte Market Size, FY'2007 - FY'2013
8.3. India Blood Gas and Electrolyte Market Segmentation by Reagents and Instruments, FY'2007-FY'2013
8.4. Market Share of Major Players in India Blood Gas and Electrolyte Market, FY'2013
9. India Molecular Diagnostics Market
9.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
9.2. India Molecular Diagnostics Market Size, FY'2007 - FY'2013
9.3. India Molecular Diagnostics Market Segmentation by Reagents and Instruments, FY'2007-FY'2013
10. India Urinalysis Market
10.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
10.2. India Urinalysis Market Size, FY'2007 - FY'2013
10.3. India Urinalysis Market Segmentation by Reagents and Instruments, FY'2007-FY'2013
11. India Coagulation Diagnostics Market
11.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
11.2. India Coagulation Diagnostics Market Size, FY'2007 - FY'2013
11.3. India Coagulation Diagnostics Market Segmentation by Reagents and Instruments, FY'2007-FY'2013
12. India In-Vitro Diagnostics Market Trends and Developments
Mounting Demand for Decentralized Laboratory Tests
Increasing Penetration in Rural Areas
Early Detection as an Emerging Trend
Inclining Automation of Labs
Increasing Consolidation
Increasing Overseas Expansion
Inclining Prevalence of Hospital Laboratory Management (HLM)
13. Market Share of Major Players in India In-Vitro Diagnostics Market, FY'2013
14. Company Profiles of Major Players in India In-Vitro Diagnostics Market
15. India In-Vitro Diagnostics Market Future Outlook and Projections, FY'2014-FY'2018
15.1. Cause and Effect Relationship Analysis of the In-vitro Diagnostics Market in India
16. Macroeconomic and Industry Factors: Historical and Projections
16.1. Population in India, FY'2007-FY'2018
16.2. Personal Disposable Income in India, FY'2007-FY'2018
16.3. Consumer Expenditure on Healthcare in India, FY'2007-FY'2018
16.4. Government Expenditure on Healthcare in India, FY'2007-FY'2018
16.5. Foreign Direct Investments in Healthcare, FY'2008-FY'2013
16.6. Private Equity Investments in Healthcare, 2009-2012
17. Appendix
17.1. Market Definitions
17.2. Abbreviations
17.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Final Conclusion
17.4. Disclaimer
List of Figure
Figure 1: India In-Vitro Diagnostics Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013
Figure 2: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Instruments and Reagents in Percentage, FY'2010-FY'2013
Figure 3: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Urban and Rural Areas in Percentage, FY'2013
Figure 4: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Different Tests in Percentage, FY'2007-FY'2013
Figure 5: India Immunochemistry Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013
Figure 6: India Immunochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments, ELISA Kits and Rapid Tests in Percentage, FY'2007-FY'2013
Figure 7: India Immunochemistry Instruments and Reagents Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013
Figure 8: India Immunochemistry Instruments and Reagents Market Segmentation on the Basis of Revenues from Instruments and Reagents in Percentage, FY'2007-FY'2013
Figure 9: India Immunochemistry Instruments and Reagents Market Segmentation on the Basis of Revenues from Different Types of Instruments and Reagents in Percentage, FY'2007-FY'2013
Figure 10: India Immunochemistry Reagents Market Segmentation on the Basis of Revenues from End Use in Different Types of Diagnostic Tests in Percentage, FY'2007-FY'2013
Figure 11: India Biochemistry Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013
Figure 12: India Biochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY'2007-FY'2013
Figure 13: India Biochemistry Instruments Market Segmentation on the Basis of Revenues from Different Types of Analyzers in Percentage, FY'2011-FY'2013
Figure 14: Market Share of Major Players on the Basis of Revenues in the Biochemistry Market in India in Percentage, FY'2013
Figure 15: India Hematology Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013
Figure 16: India Hematology Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY'2007-FY'2013
Figure 17: India Hematology Instruments Market Segmentation on the Basis of Revenues from Different Type of Instruments in Percentage, FY'2009-FY'2012
Figure 18: India Microbiology Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013
Figure 19: India Microbiology Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY'2008-FY'2013
Figure 20: India Blood Gas and Electrolyte Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013
Figure 21: India Blood Gas and Electrolyte Market Segmentation on the Basis of Revenues from Reagents and Analyzers in Percentage, FY'2007-FY'2013
Figure 22: India Blood Gas and Electrolyte Analyzers Market Segmentation on the Basis of Revenues from Different Types of Analyzers in Percentage, FY'2009-FY'2013
Figure 23: Market Share of Major Players on the Basis of Revenues in the Blood Gas and Electrolyte Market in Percentage, FY'2013
Figure 24: India Molecular Diagnostics Market Size on the Basis of Revenues in USD Million, FY'2007-FY2013
Figure 25: India Molecular Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY'2007-FY'2013
Figure 26: India Urinalysis Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013
Figure 27: India Urinalysis Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY'2007-FY'2013
Figure 28: India Coagulation Diagnostics Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013
Figure 29: India Coagulation Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY'2007-FY'2013
Figure 30: Market Share of Major Players on the Basis of Revenues in the India In-Vitro Diagnostics Market in Percentage, FY'2013
Figure 31: India In-Vitro Diagnostics Market Future Projections on the Basis of Revenues in USD Million, FY'2014-FY'2018
Figure 32: Population in India in Million, FY'2007-FY'2018
Figure 33: Personal Disposable Incomes in India in USD Million, FY'2007-FY'2018
Figure 34: Consumer Expenditure on Healthcare and Medical Services in India in USD Million, FY'2007-FY'2018
Figure 35: Government Expenditure on Health Care in India in USD Million, FY'2007-FY'2018
Figure 36: Foreign Direct Investment in Healthcare Sector in India in USD Million, FY'2008-FY'2013
Figure 37: Private Equity Investments in Healthcare Sector in India in USD Million, 2009-2012
List of Table
Table 1: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Instruments and Reagents in USD Million, FY'2010-FY'2013
Table 2: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Different Tests in USD Million, FY'2007-FY'2013
Table 3: India Immunochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments, ELISA Kits and Rapid Tests in USD Million, FY'2007-FY'2013
Table 4: India Immunochemistry Instruments and Reagents Market Segmentation on the Basis of Revenues from Instruments and Reagents in USD Million, FY'2007-FY'2013
Table 5: Market Share of Major Players on the Basis of Revenues in the Immunochemistry Market in India in Percentage, FY'2013
Table 6: India Biochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY'2007-FY'2013
Table 7: India Hematology Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY'2007-FY'2013
Table 8: Major Players in Hematology Instruments and Reagents Market in India
Table 9: India Microbiology Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY'2008-FY'2013
Table 10: Market Share of Major Players on the Basis of Revenues in the Hematology Reagents Market in Percentage, FY'2013
Table 11: India Blood Gas and Electrolyte Market Segmentation on the Basis of Revenues from Reagents and Analyzers in USD Million, FY'2007-FY'2013
Table 12: Major Players in the India Blood Gas and Electrolyte Market
Table 13: India Molecular Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY'2007-FY'2013
Table 14: India Urinalysis Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY'2007-FY'2013
Table 15: India Urinalysis Analyzers Market Segmentation on the Basis of Sales Quantity of Different Analyzers in Units and Percentage USD Million, FY'2012
Table 16: India Coagulation Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY'2007-FY'2013
Table 17: Company Profile of Major Players (Roche Diagnostic, Abbott Laboratories, Transasia Biomedicals, Siemens Healthcare, Beckman Coulter, Becton and Dickinson and Sysmex) in India In-Vitro Diagnostic Market
Table 18: Cause and Effect Relationship Analysis between Industry Factors and Expected In-Vitro Diagnostics Market Prospects in India
Table 19: India Population Segmentation on the Basis of People Residing in Urban and Rural Areas in Million, FY'2007-FY'2013
Table 20: Correlation Matrix of the India In-Vitro Diagnostics Market
Table 21: Regression Coefficients Output
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.